NCT03995602

Brief Summary

Native to South America and South East Asia, the dragon fruit (pitaya) has become increasingly popular world-wide due to their vivid hue and bizarre structure. More importantly, their high levels of bioactive phytochemical betalains has sparked considerable scientific interest. Recent findings from in vitro and in vivo animal studies tentatively suggest that betalains may have ameliorative effects on vascular function. This will be a first randomised controlled trial aimed to explore the impact of dragon fruit consumption on blood pressure and other vascular parameters in healthy individuals. The study will feature a randomised, double-blinded, placebo-controlled and crossover design with flow-mediated dilatation (FMD) as primary outcome along with blood pressure and arterial stiffness as secondary outcomes. Cardiovascular biomarkers as well as relevant metabolites will also be determined from blood and urine samples collected from participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 18, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 22, 2020

Completed
Last Updated

June 7, 2021

Status Verified

June 1, 2021

Enrollment Period

7 months

First QC Date

June 20, 2019

Last Update Submit

June 4, 2021

Conditions

Keywords

vascular functionendothelial functionbetalainsdragon fruitpitaya

Outcome Measures

Primary Outcomes (1)

  • Changes in flow mediated dilation (FMD) of the brachial artery

    Determine changes in flow mediated dilation (FMD) of the brachial artery after 2 weeks consumption of 24 g freeze-dried dragon fruit.

    Baseline & 2 weeks

Secondary Outcomes (8)

  • Changes in flow mediated dilation (FMD) of the brachial artery

    Baseline & 2, 3 and 4 hour post-consumption

  • Changes in blood pressure

    Baseline & 2, 3 and 4 hour post-consumption

  • Changes in blood pressure

    Baseline & 2 weeks

  • Changes in heart rate

    Baseline & 2, 3 and 4 hour and 2 weeks post-consumption

  • Changes blood flow velocity

    Baseline & 2, 3 and 4 hour and 2 weeks post-consumption

  • +3 more secondary outcomes

Other Outcomes (1)

  • Plasma and urine betalains and (poly)phenol metabolites

    Baseline and 3 hours and 2 weeks post consumption

Study Arms (2)

Dragon fruit first then placebo

EXPERIMENTAL

2 weeks of dragon fruit juice intake or placebo with crossover to the other

Dietary Supplement: Dragon fruit juice drinkDietary Supplement: Placebo

Placebo first then dragon fruit

EXPERIMENTAL

2 weeks of dragon fruit juice intake or placebo with crossover to the other

Dietary Supplement: Dragon fruit juice drinkDietary Supplement: Placebo

Interventions

Dragon fruit juice drinkDIETARY_SUPPLEMENT

Dragon fruit drink containing 24 g of freeze-dried dragon fruit powder dissolved in low nitrate water.

Dragon fruit first then placeboPlacebo first then dragon fruit
PlaceboDIETARY_SUPPLEMENT

Drink with macro- and micro-nutrient matched against the intervention drink.

Dragon fruit first then placeboPlacebo first then dragon fruit

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women aged 18-40 years old
  • Subjects are willing to maintain their normal eating/drinking habits and exercise habits to avoid changes in body.
  • weight over the duration of the study.
  • Are able to understand the nature of the study.
  • Able to give signed written informed consent.
  • Signed informed consent form.

You may not qualify if:

  • Medical history of cardiovascular disease including coronary artery disease, cerebrovascular disease and peripheral artery disease.
  • Hypertensive, as defined as SBP superior or equal to 140 mmHg.
  • Obese participants, defined as BMI superior or equal to 30.
  • Medical history of diabetes mellitus, metabolic syndrome, terminal renal failure or malignancies.
  • Abnormal heart rhythm (lower or higher than 60-100 bpm).
  • Allergies to dragon fruit, cactus pear or other significant food allergy.
  • Subjects under medication that can affect the cardiovascular system or on vitamin/dietary supplements.
  • Subjects who have lost more than 10% of their weight in the past 6 months or are currently in a diet
  • Subjects who reported participant in another study within one month before the study start.
  • Subjects who smokes.
  • Pregnant women or planning to become pregnant in the next 6 months.
  • Any reason or condition that in the judgment of the clinical investigator(s) may put the subject at unacceptable risk or that may preclude the subject from understanding or complying with the study's requirements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College London

London, England, SE1 9NH, United Kingdom

Location

Related Publications (1)

  • Cheok A, Xu Y, Zhang Z, Caton PW, Rodriguez-Mateos A. Betalain-rich dragon fruit (pitaya) consumption improves vascular function in men and women: a double-blind, randomized controlled crossover trial. Am J Clin Nutr. 2022 May 1;115(5):1418-1431. doi: 10.1093/ajcn/nqab410.

Study Officials

  • Ana Rodriguez-Mateos, PhD

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Nutritional Sciences

Study Record Dates

First Submitted

June 20, 2019

First Posted

June 24, 2019

Study Start

June 18, 2019

Primary Completion

January 22, 2020

Study Completion

January 22, 2020

Last Updated

June 7, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations